|
|
|
Results from the largest controlled clinical trial of fluid management methods in patients with severe lung injury provide important new information on the risks and benefits of patient care strategies currently used in the intensive care unit. The two studies that comprised the trial showed that for patients with acute lung injury or its more severe form, acute respiratory distress syndrome, less fluid is better than more, and a shorter, less invasive catheter is as helpful as and safer than a longer catheter for monitoring patients. The trial was conducted by scientists from the Acute Respiratory Distress Syndrome Clinical Research Network of the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.
Investigators from the Fluid and Catheter Treatment Trial (FACTT) presented the findings May 21 at the American Thoracic Society (ATS) International Conference in San Diego, California. The results were also published early online by the New England Journal of Medicine (NEJM). The study comparing the use of the longer pulmonary artery catheter to the shorter central venous catheter for managing patients will be published in the May 25 print issue of NEJM; the study evaluating fluid management strategies will appear in the June 15 print issue of NEJM. CONTACT:
NHLBI Communications Office
301-496-4236
Message posted by: Rashmi Nemade
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|